nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—CYP2C19—coronary artery disease	0.344	1	CbGaD
Methsuximide—CYP2C19—Gemfibrozil—coronary artery disease	0.0587	0.16	CbGbCtD
Methsuximide—CACNA1G—sinoatrial node—coronary artery disease	0.054	0.919	CbGeAlD
Methsuximide—CYP2C19—Clopidogrel—coronary artery disease	0.0509	0.139	CbGbCtD
Methsuximide—CYP2C19—Telmisartan—coronary artery disease	0.0445	0.121	CbGbCtD
Methsuximide—CYP2C19—Timolol—coronary artery disease	0.0359	0.0977	CbGbCtD
Methsuximide—CYP2C19—Rosuvastatin—coronary artery disease	0.0328	0.0894	CbGbCtD
Methsuximide—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.032	0.0871	CbGbCtD
Methsuximide—CYP2C19—Simvastatin—coronary artery disease	0.0305	0.0831	CbGbCtD
Methsuximide—CYP2C19—Lovastatin—coronary artery disease	0.0298	0.0813	CbGbCtD
Methsuximide—CYP2C19—Atorvastatin—coronary artery disease	0.0272	0.074	CbGbCtD
Methsuximide—CYP2C19—Losartan—coronary artery disease	0.0249	0.0677	CbGbCtD
Methsuximide—CACNA1H—heart—coronary artery disease	0.00206	0.0351	CbGeAlD
Methsuximide—CACNA1H—cardiovascular system—coronary artery disease	0.00194	0.0331	CbGeAlD
Methsuximide—CYP2C19—blood—coronary artery disease	0.000732	0.0125	CbGeAlD
Methsuximide—Aminophenazone—CYP2C19—coronary artery disease	0.000499	0.158	CrCbGaD
Methsuximide—Phensuximide—CYP2C19—coronary artery disease	0.000354	0.112	CrCbGaD
Methsuximide—Antipyrine—CYP2C19—coronary artery disease	0.000314	0.0998	CrCbGaD
Methsuximide—Ethotoin—CYP2C19—coronary artery disease	0.000262	0.0833	CrCbGaD
Methsuximide—Confusional state—Losartan—coronary artery disease	0.000245	0.00138	CcSEcCtD
Methsuximide—Tension—Timolol—coronary artery disease	0.000245	0.00138	CcSEcCtD
Methsuximide—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000245	0.00138	CcSEcCtD
Methsuximide—Somnolence—Telmisartan—coronary artery disease	0.000244	0.00137	CcSEcCtD
Methsuximide—Primidone—CYP2C19—coronary artery disease	0.000243	0.0772	CrCbGaD
Methsuximide—Decreased appetite—Trandolapril—coronary artery disease	0.000243	0.00137	CcSEcCtD
Methsuximide—Nervousness—Timolol—coronary artery disease	0.000242	0.00136	CcSEcCtD
Methsuximide—Decreased appetite—Enalapril—coronary artery disease	0.000242	0.00136	CcSEcCtD
Methsuximide—Insomnia—Captopril—coronary artery disease	0.000241	0.00136	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000241	0.00136	CcSEcCtD
Methsuximide—Anorexia—Furosemide—coronary artery disease	0.00024	0.00135	CcSEcCtD
Methsuximide—Gastrointestinal pain—Niacin—coronary artery disease	0.000239	0.00134	CcSEcCtD
Methsuximide—Constipation—Trandolapril—coronary artery disease	0.000239	0.00134	CcSEcCtD
Methsuximide—Urticaria—Valsartan—coronary artery disease	0.000239	0.00134	CcSEcCtD
Methsuximide—Decreased appetite—Telmisartan—coronary artery disease	0.000239	0.00134	CcSEcCtD
Methsuximide—Nausea—Rosuvastatin—coronary artery disease	0.000238	0.00134	CcSEcCtD
Methsuximide—Diarrhoea—Fenofibrate—coronary artery disease	0.000238	0.00134	CcSEcCtD
Methsuximide—Constipation—Enalapril—coronary artery disease	0.000238	0.00134	CcSEcCtD
Methsuximide—Urticaria—Olmesartan—coronary artery disease	0.000238	0.00134	CcSEcCtD
Methsuximide—Abdominal pain—Valsartan—coronary artery disease	0.000238	0.00134	CcSEcCtD
Methsuximide—Somnolence—Captopril—coronary artery disease	0.000237	0.00133	CcSEcCtD
Methsuximide—Feeling abnormal—Pravastatin—coronary artery disease	0.000237	0.00133	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000237	0.00133	CcSEcCtD
Methsuximide—Abdominal pain—Olmesartan—coronary artery disease	0.000236	0.00133	CcSEcCtD
Methsuximide—Vision blurred—Timolol—coronary artery disease	0.000235	0.00132	CcSEcCtD
Methsuximide—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000235	0.00132	CcSEcCtD
Methsuximide—Constipation—Telmisartan—coronary artery disease	0.000235	0.00132	CcSEcCtD
Methsuximide—Insomnia—Perindopril—coronary artery disease	0.000234	0.00132	CcSEcCtD
Methsuximide—Diarrhoea—Clopidogrel—coronary artery disease	0.000234	0.00132	CcSEcCtD
Methsuximide—Diarrhoea—Lovastatin—coronary artery disease	0.000233	0.00131	CcSEcCtD
Methsuximide—Urticaria—Niacin—coronary artery disease	0.000232	0.00131	CcSEcCtD
Methsuximide—Decreased appetite—Captopril—coronary artery disease	0.000232	0.00131	CcSEcCtD
Methsuximide—Anorexia—Losartan—coronary artery disease	0.000232	0.0013	CcSEcCtD
Methsuximide—Nausea—Acetylsalicylic acid—coronary artery disease	0.000232	0.0013	CcSEcCtD
Methsuximide—Abdominal pain—Niacin—coronary artery disease	0.000231	0.0013	CcSEcCtD
Methsuximide—Dizziness—Fenofibrate—coronary artery disease	0.00023	0.0013	CcSEcCtD
Methsuximide—Somnolence—Perindopril—coronary artery disease	0.00023	0.0013	CcSEcCtD
Methsuximide—Feeling abnormal—Trandolapril—coronary artery disease	0.00023	0.0013	CcSEcCtD
Methsuximide—Feeling abnormal—Enalapril—coronary artery disease	0.000229	0.00129	CcSEcCtD
Methsuximide—Leukopenia—Ramipril—coronary artery disease	0.000229	0.00129	CcSEcCtD
Methsuximide—Urticaria—Pravastatin—coronary artery disease	0.000229	0.00129	CcSEcCtD
Methsuximide—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000228	0.00129	CcSEcCtD
Methsuximide—Diarrhoea—Ezetimibe—coronary artery disease	0.000228	0.00128	CcSEcCtD
Methsuximide—Constipation—Captopril—coronary artery disease	0.000228	0.00128	CcSEcCtD
Methsuximide—Methylphenobarbital—CYP2C19—coronary artery disease	0.000228	0.0724	CrCbGaD
Methsuximide—Gastrointestinal pain—Enalapril—coronary artery disease	0.000228	0.00128	CcSEcCtD
Methsuximide—Abdominal pain—Pravastatin—coronary artery disease	0.000227	0.00128	CcSEcCtD
Methsuximide—Tension—Lisinopril—coronary artery disease	0.000227	0.00128	CcSEcCtD
Methsuximide—Dizziness—Clopidogrel—coronary artery disease	0.000226	0.00127	CcSEcCtD
Methsuximide—Feeling abnormal—Telmisartan—coronary artery disease	0.000226	0.00127	CcSEcCtD
Methsuximide—Decreased appetite—Perindopril—coronary artery disease	0.000225	0.00127	CcSEcCtD
Methsuximide—Dizziness—Lovastatin—coronary artery disease	0.000225	0.00127	CcSEcCtD
Methsuximide—Nervousness—Lisinopril—coronary artery disease	0.000225	0.00127	CcSEcCtD
Methsuximide—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000224	0.00126	CcSEcCtD
Methsuximide—Somnolence—Furosemide—coronary artery disease	0.000224	0.00126	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000224	0.00126	CcSEcCtD
Methsuximide—Diarrhoea—Eplerenone—coronary artery disease	0.000223	0.00126	CcSEcCtD
Methsuximide—Urticaria—Trandolapril—coronary artery disease	0.000222	0.00125	CcSEcCtD
Methsuximide—Constipation—Perindopril—coronary artery disease	0.000222	0.00125	CcSEcCtD
Methsuximide—Vomiting—Fenofibrate—coronary artery disease	0.000222	0.00125	CcSEcCtD
Methsuximide—Urticaria—Enalapril—coronary artery disease	0.000221	0.00124	CcSEcCtD
Methsuximide—Abdominal pain—Trandolapril—coronary artery disease	0.000221	0.00124	CcSEcCtD
Methsuximide—Dizziness—Ezetimibe—coronary artery disease	0.000221	0.00124	CcSEcCtD
Methsuximide—Abdominal pain—Enalapril—coronary artery disease	0.00022	0.00124	CcSEcCtD
Methsuximide—Feeling abnormal—Captopril—coronary artery disease	0.00022	0.00124	CcSEcCtD
Methsuximide—Insomnia—Losartan—coronary artery disease	0.00022	0.00124	CcSEcCtD
Methsuximide—Rash—Fenofibrate—coronary artery disease	0.00022	0.00124	CcSEcCtD
Methsuximide—Dermatitis—Fenofibrate—coronary artery disease	0.000219	0.00123	CcSEcCtD
Methsuximide—Decreased appetite—Furosemide—coronary artery disease	0.000219	0.00123	CcSEcCtD
Methsuximide—Headache—Fenofibrate—coronary artery disease	0.000218	0.00123	CcSEcCtD
Methsuximide—Vision blurred—Lisinopril—coronary artery disease	0.000218	0.00123	CcSEcCtD
Methsuximide—Gastrointestinal pain—Captopril—coronary artery disease	0.000218	0.00123	CcSEcCtD
Methsuximide—Urticaria—Telmisartan—coronary artery disease	0.000218	0.00123	CcSEcCtD
Methsuximide—Vomiting—Clopidogrel—coronary artery disease	0.000218	0.00123	CcSEcCtD
Methsuximide—Diarrhoea—Simvastatin—coronary artery disease	0.000218	0.00123	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000217	0.00122	CcSEcCtD
Methsuximide—Pethidine—CYP2C19—coronary artery disease	0.000217	0.069	CrCbGaD
Methsuximide—Abdominal pain—Telmisartan—coronary artery disease	0.000217	0.00122	CcSEcCtD
Methsuximide—Vomiting—Lovastatin—coronary artery disease	0.000216	0.00122	CcSEcCtD
Methsuximide—Somnolence—Losartan—coronary artery disease	0.000216	0.00122	CcSEcCtD
Methsuximide—Dizziness—Eplerenone—coronary artery disease	0.000216	0.00122	CcSEcCtD
Methsuximide—Rash—Clopidogrel—coronary artery disease	0.000216	0.00121	CcSEcCtD
Methsuximide—Dermatitis—Clopidogrel—coronary artery disease	0.000216	0.00121	CcSEcCtD
Methsuximide—Constipation—Furosemide—coronary artery disease	0.000215	0.00121	CcSEcCtD
Methsuximide—Headache—Clopidogrel—coronary artery disease	0.000215	0.00121	CcSEcCtD
Methsuximide—Rash—Lovastatin—coronary artery disease	0.000214	0.00121	CcSEcCtD
Methsuximide—Dermatitis—Lovastatin—coronary artery disease	0.000214	0.00121	CcSEcCtD
Methsuximide—Feeling abnormal—Perindopril—coronary artery disease	0.000214	0.0012	CcSEcCtD
Methsuximide—Headache—Lovastatin—coronary artery disease	0.000213	0.0012	CcSEcCtD
Methsuximide—Vomiting—Ezetimibe—coronary artery disease	0.000212	0.00119	CcSEcCtD
Methsuximide—Gastrointestinal pain—Perindopril—coronary artery disease	0.000212	0.00119	CcSEcCtD
Methsuximide—Decreased appetite—Losartan—coronary artery disease	0.000211	0.00119	CcSEcCtD
Methsuximide—Abdominal pain—Captopril—coronary artery disease	0.000211	0.00119	CcSEcCtD
Methsuximide—Dizziness—Simvastatin—coronary artery disease	0.00021	0.00118	CcSEcCtD
Methsuximide—Rash—Ezetimibe—coronary artery disease	0.00021	0.00118	CcSEcCtD
Methsuximide—Dermatitis—Ezetimibe—coronary artery disease	0.00021	0.00118	CcSEcCtD
Methsuximide—Confusional state—Ramipril—coronary artery disease	0.00021	0.00118	CcSEcCtD
Methsuximide—Headache—Ezetimibe—coronary artery disease	0.000209	0.00118	CcSEcCtD
Methsuximide—Constipation—Losartan—coronary artery disease	0.000208	0.00117	CcSEcCtD
Methsuximide—Vomiting—Eplerenone—coronary artery disease	0.000208	0.00117	CcSEcCtD
Methsuximide—Feeling abnormal—Furosemide—coronary artery disease	0.000208	0.00117	CcSEcCtD
Methsuximide—Leukopenia—Lisinopril—coronary artery disease	0.000207	0.00117	CcSEcCtD
Methsuximide—Nausea—Fenofibrate—coronary artery disease	0.000207	0.00116	CcSEcCtD
Methsuximide—Gastrointestinal pain—Furosemide—coronary artery disease	0.000206	0.00116	CcSEcCtD
Methsuximide—Rash—Eplerenone—coronary artery disease	0.000206	0.00116	CcSEcCtD
Methsuximide—Urticaria—Perindopril—coronary artery disease	0.000206	0.00116	CcSEcCtD
Methsuximide—Dermatitis—Eplerenone—coronary artery disease	0.000206	0.00116	CcSEcCtD
Methsuximide—Diarrhoea—Valsartan—coronary artery disease	0.000206	0.00116	CcSEcCtD
Methsuximide—Confusional state—Timolol—coronary artery disease	0.000205	0.00116	CcSEcCtD
Methsuximide—Abdominal pain—Perindopril—coronary artery disease	0.000205	0.00115	CcSEcCtD
Methsuximide—Diarrhoea—Olmesartan—coronary artery disease	0.000205	0.00115	CcSEcCtD
Methsuximide—Headache—Eplerenone—coronary artery disease	0.000205	0.00115	CcSEcCtD
Methsuximide—Nausea—Clopidogrel—coronary artery disease	0.000203	0.00114	CcSEcCtD
Methsuximide—Vomiting—Simvastatin—coronary artery disease	0.000202	0.00114	CcSEcCtD
Methsuximide—Nausea—Lovastatin—coronary artery disease	0.000202	0.00114	CcSEcCtD
Methsuximide—Rash—Simvastatin—coronary artery disease	0.000201	0.00113	CcSEcCtD
Methsuximide—Dermatitis—Simvastatin—coronary artery disease	0.0002	0.00113	CcSEcCtD
Methsuximide—Feeling abnormal—Losartan—coronary artery disease	0.0002	0.00113	CcSEcCtD
Methsuximide—Urticaria—Furosemide—coronary artery disease	0.0002	0.00113	CcSEcCtD
Methsuximide—Diarrhoea—Niacin—coronary artery disease	0.0002	0.00112	CcSEcCtD
Methsuximide—Headache—Simvastatin—coronary artery disease	0.000199	0.00112	CcSEcCtD
Methsuximide—Abdominal pain—Furosemide—coronary artery disease	0.000199	0.00112	CcSEcCtD
Methsuximide—Gastrointestinal pain—Losartan—coronary artery disease	0.000199	0.00112	CcSEcCtD
Methsuximide—Dizziness—Valsartan—coronary artery disease	0.000199	0.00112	CcSEcCtD
Methsuximide—Anorexia—Ramipril—coronary artery disease	0.000199	0.00112	CcSEcCtD
Methsuximide—Nausea—Ezetimibe—coronary artery disease	0.000198	0.00112	CcSEcCtD
Methsuximide—Dizziness—Olmesartan—coronary artery disease	0.000198	0.00111	CcSEcCtD
Methsuximide—Diarrhoea—Pravastatin—coronary artery disease	0.000197	0.00111	CcSEcCtD
Methsuximide—Antipyrine—PTGS2—coronary artery disease	0.000196	0.0621	CrCbGaD
Methsuximide—Anorexia—Timolol—coronary artery disease	0.000194	0.00109	CcSEcCtD
Methsuximide—Nausea—Eplerenone—coronary artery disease	0.000194	0.00109	CcSEcCtD
Methsuximide—Dizziness—Niacin—coronary artery disease	0.000193	0.00109	CcSEcCtD
Methsuximide—Urticaria—Losartan—coronary artery disease	0.000193	0.00109	CcSEcCtD
Methsuximide—Abdominal pain—Losartan—coronary artery disease	0.000192	0.00108	CcSEcCtD
Methsuximide—Diarrhoea—Trandolapril—coronary artery disease	0.000191	0.00108	CcSEcCtD
Methsuximide—Vomiting—Valsartan—coronary artery disease	0.000191	0.00108	CcSEcCtD
Methsuximide—Confusional state—Lisinopril—coronary artery disease	0.000191	0.00107	CcSEcCtD
Methsuximide—Diarrhoea—Enalapril—coronary artery disease	0.00019	0.00107	CcSEcCtD
Methsuximide—Dizziness—Pravastatin—coronary artery disease	0.00019	0.00107	CcSEcCtD
Methsuximide—Vomiting—Olmesartan—coronary artery disease	0.00019	0.00107	CcSEcCtD
Methsuximide—Rash—Valsartan—coronary artery disease	0.000189	0.00107	CcSEcCtD
Methsuximide—Dermatitis—Valsartan—coronary artery disease	0.000189	0.00107	CcSEcCtD
Methsuximide—Nausea—Simvastatin—coronary artery disease	0.000189	0.00106	CcSEcCtD
Methsuximide—Rash—Olmesartan—coronary artery disease	0.000189	0.00106	CcSEcCtD
Methsuximide—Insomnia—Ramipril—coronary artery disease	0.000188	0.00106	CcSEcCtD
Methsuximide—Dermatitis—Olmesartan—coronary artery disease	0.000188	0.00106	CcSEcCtD
Methsuximide—Headache—Valsartan—coronary artery disease	0.000188	0.00106	CcSEcCtD
Methsuximide—Diarrhoea—Telmisartan—coronary artery disease	0.000188	0.00106	CcSEcCtD
Methsuximide—Headache—Olmesartan—coronary artery disease	0.000187	0.00105	CcSEcCtD
Methsuximide—Vomiting—Niacin—coronary artery disease	0.000186	0.00105	CcSEcCtD
Methsuximide—Somnolence—Ramipril—coronary artery disease	0.000185	0.00104	CcSEcCtD
Methsuximide—Dizziness—Trandolapril—coronary artery disease	0.000185	0.00104	CcSEcCtD
Methsuximide—Insomnia—Timolol—coronary artery disease	0.000184	0.00104	CcSEcCtD
Methsuximide—Rash—Niacin—coronary artery disease	0.000184	0.00104	CcSEcCtD
Methsuximide—Dermatitis—Niacin—coronary artery disease	0.000184	0.00104	CcSEcCtD
Methsuximide—Dizziness—Enalapril—coronary artery disease	0.000184	0.00104	CcSEcCtD
Methsuximide—Headache—Niacin—coronary artery disease	0.000183	0.00103	CcSEcCtD
Methsuximide—Vomiting—Pravastatin—coronary artery disease	0.000183	0.00103	CcSEcCtD
Methsuximide—Diarrhoea—Captopril—coronary artery disease	0.000183	0.00103	CcSEcCtD
Methsuximide—Dizziness—Telmisartan—coronary artery disease	0.000181	0.00102	CcSEcCtD
Methsuximide—Rash—Pravastatin—coronary artery disease	0.000181	0.00102	CcSEcCtD
Methsuximide—Dermatitis—Pravastatin—coronary artery disease	0.000181	0.00102	CcSEcCtD
Methsuximide—Decreased appetite—Ramipril—coronary artery disease	0.000181	0.00102	CcSEcCtD
Methsuximide—Somnolence—Timolol—coronary artery disease	0.000181	0.00102	CcSEcCtD
Methsuximide—Headache—Pravastatin—coronary artery disease	0.00018	0.00101	CcSEcCtD
Methsuximide—Anorexia—Lisinopril—coronary artery disease	0.00018	0.00101	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Ramipril—coronary artery disease	0.00018	0.00101	CcSEcCtD
Methsuximide—Nausea—Valsartan—coronary artery disease	0.000178	0.001	CcSEcCtD
Methsuximide—Constipation—Ramipril—coronary artery disease	0.000178	0.001	CcSEcCtD
Methsuximide—Nausea—Olmesartan—coronary artery disease	0.000178	0.000999	CcSEcCtD
Methsuximide—Vomiting—Trandolapril—coronary artery disease	0.000178	0.000999	CcSEcCtD
Methsuximide—Diarrhoea—Perindopril—coronary artery disease	0.000177	0.000998	CcSEcCtD
Methsuximide—Decreased appetite—Timolol—coronary artery disease	0.000177	0.000996	CcSEcCtD
Methsuximide—Vomiting—Enalapril—coronary artery disease	0.000177	0.000995	CcSEcCtD
Methsuximide—Dizziness—Captopril—coronary artery disease	0.000176	0.000993	CcSEcCtD
Methsuximide—Rash—Trandolapril—coronary artery disease	0.000176	0.000991	CcSEcCtD
Methsuximide—Dermatitis—Trandolapril—coronary artery disease	0.000176	0.00099	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Timolol—coronary artery disease	0.000176	0.00099	CcSEcCtD
Methsuximide—Clobazam—CYP2C19—coronary artery disease	0.000176	0.0557	CrCbGaD
Methsuximide—Rash—Enalapril—coronary artery disease	0.000175	0.000987	CcSEcCtD
Methsuximide—Dermatitis—Enalapril—coronary artery disease	0.000175	0.000986	CcSEcCtD
Methsuximide—Headache—Trandolapril—coronary artery disease	0.000175	0.000985	CcSEcCtD
Methsuximide—Vomiting—Telmisartan—coronary artery disease	0.000174	0.000982	CcSEcCtD
Methsuximide—Headache—Enalapril—coronary artery disease	0.000174	0.000981	CcSEcCtD
Methsuximide—Nausea—Niacin—coronary artery disease	0.000174	0.000977	CcSEcCtD
Methsuximide—Rash—Telmisartan—coronary artery disease	0.000173	0.000974	CcSEcCtD
Methsuximide—Dermatitis—Telmisartan—coronary artery disease	0.000173	0.000973	CcSEcCtD
Methsuximide—Diarrhoea—Furosemide—coronary artery disease	0.000172	0.00097	CcSEcCtD
Methsuximide—Headache—Telmisartan—coronary artery disease	0.000172	0.000967	CcSEcCtD
Methsuximide—Feeling abnormal—Ramipril—coronary artery disease	0.000172	0.000966	CcSEcCtD
Methsuximide—Dizziness—Perindopril—coronary artery disease	0.000171	0.000964	CcSEcCtD
Methsuximide—Insomnia—Lisinopril—coronary artery disease	0.000171	0.000962	CcSEcCtD
Methsuximide—Nausea—Pravastatin—coronary artery disease	0.000171	0.000961	CcSEcCtD
Methsuximide—Gastrointestinal pain—Ramipril—coronary artery disease	0.00017	0.000959	CcSEcCtD
Methsuximide—Vomiting—Captopril—coronary artery disease	0.00017	0.000955	CcSEcCtD
Methsuximide—Rash—Captopril—coronary artery disease	0.000168	0.000947	CcSEcCtD
Methsuximide—Dermatitis—Captopril—coronary artery disease	0.000168	0.000946	CcSEcCtD
Methsuximide—Somnolence—Lisinopril—coronary artery disease	0.000168	0.000945	CcSEcCtD
Methsuximide—Feeling abnormal—Timolol—coronary artery disease	0.000168	0.000945	CcSEcCtD
Methsuximide—Headache—Captopril—coronary artery disease	0.000167	0.000941	CcSEcCtD
Methsuximide—Gastrointestinal pain—Timolol—coronary artery disease	0.000167	0.000937	CcSEcCtD
Methsuximide—Dizziness—Furosemide—coronary artery disease	0.000167	0.000937	CcSEcCtD
Methsuximide—Diarrhoea—Losartan—coronary artery disease	0.000166	0.000936	CcSEcCtD
Methsuximide—Nausea—Trandolapril—coronary artery disease	0.000166	0.000934	CcSEcCtD
Methsuximide—Urticaria—Ramipril—coronary artery disease	0.000166	0.000931	CcSEcCtD
Methsuximide—Nausea—Enalapril—coronary artery disease	0.000165	0.00093	CcSEcCtD
Methsuximide—Vomiting—Perindopril—coronary artery disease	0.000165	0.000927	CcSEcCtD
Methsuximide—Abdominal pain—Ramipril—coronary artery disease	0.000165	0.000927	CcSEcCtD
Methsuximide—Decreased appetite—Lisinopril—coronary artery disease	0.000164	0.000924	CcSEcCtD
Methsuximide—Rash—Perindopril—coronary artery disease	0.000163	0.000919	CcSEcCtD
Methsuximide—Dermatitis—Perindopril—coronary artery disease	0.000163	0.000918	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000163	0.000918	CcSEcCtD
Methsuximide—Nausea—Telmisartan—coronary artery disease	0.000163	0.000917	CcSEcCtD
Methsuximide—Headache—Perindopril—coronary artery disease	0.000162	0.000913	CcSEcCtD
Methsuximide—Urticaria—Timolol—coronary artery disease	0.000162	0.000911	CcSEcCtD
Methsuximide—Constipation—Lisinopril—coronary artery disease	0.000162	0.000909	CcSEcCtD
Methsuximide—Abdominal pain—Timolol—coronary artery disease	0.000161	0.000906	CcSEcCtD
Methsuximide—Dizziness—Losartan—coronary artery disease	0.000161	0.000904	CcSEcCtD
Methsuximide—Vomiting—Furosemide—coronary artery disease	0.00016	0.000901	CcSEcCtD
Methsuximide—Phenytoin—CYP2C19—coronary artery disease	0.00016	0.0508	CrCbGaD
Methsuximide—Rash—Furosemide—coronary artery disease	0.000159	0.000894	CcSEcCtD
Methsuximide—Dermatitis—Furosemide—coronary artery disease	0.000159	0.000893	CcSEcCtD
Methsuximide—Nausea—Captopril—coronary artery disease	0.000159	0.000892	CcSEcCtD
Methsuximide—Headache—Furosemide—coronary artery disease	0.000158	0.000888	CcSEcCtD
Methsuximide—Feeling abnormal—Lisinopril—coronary artery disease	0.000156	0.000876	CcSEcCtD
Methsuximide—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000155	0.00087	CcSEcCtD
Methsuximide—Vomiting—Losartan—coronary artery disease	0.000155	0.000869	CcSEcCtD
Methsuximide—Nausea—Perindopril—coronary artery disease	0.000154	0.000866	CcSEcCtD
Methsuximide—Phenobarbital—CYP2C19—coronary artery disease	0.000154	0.0487	CrCbGaD
Methsuximide—Rash—Losartan—coronary artery disease	0.000153	0.000862	CcSEcCtD
Methsuximide—Dermatitis—Losartan—coronary artery disease	0.000153	0.000861	CcSEcCtD
Methsuximide—Headache—Losartan—coronary artery disease	0.000152	0.000857	CcSEcCtD
Methsuximide—Urticaria—Lisinopril—coronary artery disease	0.00015	0.000845	CcSEcCtD
Methsuximide—Nausea—Furosemide—coronary artery disease	0.00015	0.000842	CcSEcCtD
Methsuximide—Abdominal pain—Lisinopril—coronary artery disease	0.000149	0.000841	CcSEcCtD
Methsuximide—Nausea—Losartan—coronary artery disease	0.000144	0.000812	CcSEcCtD
Methsuximide—Diarrhoea—Ramipril—coronary artery disease	0.000143	0.000802	CcSEcCtD
Methsuximide—Diarrhoea—Timolol—coronary artery disease	0.000139	0.000784	CcSEcCtD
Methsuximide—Ketazolam—ALB—coronary artery disease	0.000138	0.0437	CrCbGaD
Methsuximide—Dizziness—Ramipril—coronary artery disease	0.000138	0.000775	CcSEcCtD
Methsuximide—Dizziness—Timolol—coronary artery disease	0.000135	0.000758	CcSEcCtD
Methsuximide—Vomiting—Ramipril—coronary artery disease	0.000132	0.000746	CcSEcCtD
Methsuximide—Rash—Ramipril—coronary artery disease	0.000131	0.000739	CcSEcCtD
Methsuximide—Dermatitis—Ramipril—coronary artery disease	0.000131	0.000739	CcSEcCtD
Methsuximide—Headache—Ramipril—coronary artery disease	0.000131	0.000735	CcSEcCtD
Methsuximide—Vomiting—Timolol—coronary artery disease	0.00013	0.000729	CcSEcCtD
Methsuximide—Diarrhoea—Lisinopril—coronary artery disease	0.000129	0.000728	CcSEcCtD
Methsuximide—Rash—Timolol—coronary artery disease	0.000128	0.000723	CcSEcCtD
Methsuximide—Dermatitis—Timolol—coronary artery disease	0.000128	0.000722	CcSEcCtD
Methsuximide—Headache—Timolol—coronary artery disease	0.000128	0.000718	CcSEcCtD
Methsuximide—Dizziness—Lisinopril—coronary artery disease	0.000125	0.000703	CcSEcCtD
Methsuximide—Nausea—Ramipril—coronary artery disease	0.000124	0.000696	CcSEcCtD
Methsuximide—Nausea—Timolol—coronary artery disease	0.000121	0.000681	CcSEcCtD
Methsuximide—Pethidine—ALB—coronary artery disease	0.000121	0.0383	CrCbGaD
Methsuximide—Vomiting—Lisinopril—coronary artery disease	0.00012	0.000676	CcSEcCtD
Methsuximide—Rash—Lisinopril—coronary artery disease	0.000119	0.00067	CcSEcCtD
Methsuximide—Dermatitis—Lisinopril—coronary artery disease	0.000119	0.00067	CcSEcCtD
Methsuximide—Headache—Lisinopril—coronary artery disease	0.000118	0.000666	CcSEcCtD
Methsuximide—Nausea—Lisinopril—coronary artery disease	0.000112	0.000632	CcSEcCtD
Methsuximide—Phenytoin—ALB—coronary artery disease	8.88e-05	0.0282	CrCbGaD
Methsuximide—CACNA1H—Axon guidance—IL6ST—coronary artery disease	7.97e-05	0.0016	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6ST—coronary artery disease	7.96e-05	0.0016	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PPARGC1A—coronary artery disease	7.93e-05	0.00159	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—GSK3B—coronary artery disease	7.59e-05	0.00152	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—CREB1—coronary artery disease	7.53e-05	0.00151	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—LPL—coronary artery disease	7.46e-05	0.0015	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—SULT1A1—coronary artery disease	7.43e-05	0.00149	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GPX2—coronary artery disease	7.42e-05	0.00149	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MEF2C—coronary artery disease	7.39e-05	0.00148	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PPARG—coronary artery disease	7.39e-05	0.00148	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—GSK3B—coronary artery disease	7.35e-05	0.00148	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—GSK3B—coronary artery disease	7.34e-05	0.00148	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6R—coronary artery disease	7.34e-05	0.00147	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GPX4—coronary artery disease	7.33e-05	0.00147	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—SULT1A1—coronary artery disease	7.33e-05	0.00147	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—CREB1—coronary artery disease	7.29e-05	0.00146	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CREB1—coronary artery disease	7.28e-05	0.00146	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTA1—coronary artery disease	7.26e-05	0.00146	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—LPL—coronary artery disease	7.22e-05	0.00145	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ITGB3—coronary artery disease	7.2e-05	0.00145	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MEF2C—coronary artery disease	7.16e-05	0.00144	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MMP9—coronary artery disease	7.14e-05	0.00143	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6R—coronary artery disease	7.11e-05	0.00143	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6R—coronary artery disease	7.11e-05	0.00143	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CD36—coronary artery disease	7.09e-05	0.00142	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP2—coronary artery disease	7.01e-05	0.00141	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ITGB3—coronary artery disease	6.98e-05	0.0014	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CD36—coronary artery disease	6.86e-05	0.00138	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP2—coronary artery disease	6.79e-05	0.00136	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP2—coronary artery disease	6.78e-05	0.00136	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—FGF2—coronary artery disease	6.44e-05	0.00129	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—VEGFA—coronary artery disease	6.41e-05	0.00129	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—JAK2—coronary artery disease	6.38e-05	0.00128	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—LEP—coronary artery disease	6.25e-05	0.00126	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—JAK2—coronary artery disease	6.18e-05	0.00124	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—JAK2—coronary artery disease	6.17e-05	0.00124	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—KDR—coronary artery disease	6.12e-05	0.00123	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MAPK14—coronary artery disease	6.08e-05	0.00122	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPAP2B—coronary artery disease	6.07e-05	0.00122	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—LEP—coronary artery disease	6.05e-05	0.00122	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GPX3—coronary artery disease	6.02e-05	0.00121	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—KDR—coronary artery disease	5.93e-05	0.00119	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MAPK14—coronary artery disease	5.89e-05	0.00118	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6ST—coronary artery disease	5.87e-05	0.00118	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—ALDH2—coronary artery disease	5.85e-05	0.00118	CbGpPWpGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	5.82e-05	0.00117	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MAPK1—coronary artery disease	5.77e-05	0.00116	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6ST—coronary artery disease	5.69e-05	0.00114	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTT1—coronary artery disease	5.57e-05	0.00112	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GCLC—coronary artery disease	5.5e-05	0.00111	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PPARG—coronary artery disease	5.45e-05	0.00109	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—GSK3B—coronary artery disease	5.41e-05	0.00109	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CREB1—coronary artery disease	5.37e-05	0.00108	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—coronary artery disease	5.37e-05	0.00108	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PPARG—coronary artery disease	5.27e-05	0.00106	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP9—coronary artery disease	5.27e-05	0.00106	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—GSK3B—coronary artery disease	5.24e-05	0.00105	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6R—coronary artery disease	5.24e-05	0.00105	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CREB1—coronary artery disease	5.2e-05	0.00104	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP9—coronary artery disease	5.1e-05	0.00102	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP9—coronary artery disease	5.1e-05	0.00102	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6R—coronary artery disease	5.07e-05	0.00102	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GK—coronary artery disease	5.03e-05	0.00101	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCS2—coronary artery disease	5.03e-05	0.00101	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP2—coronary artery disease	5e-05	0.001	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP2—coronary artery disease	4.84e-05	0.000973	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—FGF2—coronary artery disease	4.75e-05	0.000954	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—VEGFA—coronary artery disease	4.73e-05	0.00095	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	4.72e-05	0.000948	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—UGCG—coronary artery disease	4.6e-05	0.000924	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—FGF2—coronary artery disease	4.6e-05	0.000924	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—VEGFA—coronary artery disease	4.58e-05	0.00092	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—VEGFA—coronary artery disease	4.58e-05	0.000919	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—JAK2—coronary artery disease	4.55e-05	0.000914	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—IL6—coronary artery disease	4.44e-05	0.000891	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—JAK2—coronary artery disease	4.41e-05	0.000885	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GGT1—coronary artery disease	4.3e-05	0.000863	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MAPK1—coronary artery disease	4.26e-05	0.000855	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TGFB1—coronary artery disease	4.2e-05	0.000844	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MAPK1—coronary artery disease	4.12e-05	0.000828	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MAPK1—coronary artery disease	4.12e-05	0.000827	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PLIN1—coronary artery disease	4.02e-05	0.000808	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TNF—coronary artery disease	3.92e-05	0.000788	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA5B—coronary artery disease	3.9e-05	0.000784	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTP1—coronary artery disease	3.86e-05	0.000775	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTP1—coronary artery disease	3.81e-05	0.000764	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP9—coronary artery disease	3.76e-05	0.000755	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP9—coronary artery disease	3.64e-05	0.000731	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—coronary artery disease	3.64e-05	0.000731	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTM1—coronary artery disease	3.55e-05	0.000712	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTM1—coronary artery disease	3.5e-05	0.000702	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SLC27A1—coronary artery disease	3.49e-05	0.0007	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—coronary artery disease	3.42e-05	0.000687	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—coronary artery disease	3.42e-05	0.000687	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—VEGFA—coronary artery disease	3.37e-05	0.000678	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOA4—coronary artery disease	3.36e-05	0.000674	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CKMT1B—coronary artery disease	3.32e-05	0.000666	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6—coronary artery disease	3.27e-05	0.000657	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—VEGFA—coronary artery disease	3.27e-05	0.000656	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6—coronary artery disease	3.17e-05	0.000636	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6—coronary artery disease	3.17e-05	0.000636	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—coronary artery disease	3.14e-05	0.000631	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11B2—coronary artery disease	3.14e-05	0.000631	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TGFB1—coronary artery disease	3.1e-05	0.000622	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	3.05e-05	0.000612	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	3.05e-05	0.000612	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MAPK1—coronary artery disease	3.04e-05	0.00061	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TGFB1—coronary artery disease	3e-05	0.000602	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MAPK1—coronary artery disease	2.94e-05	0.000591	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—AKT1—coronary artery disease	2.92e-05	0.000587	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TNF—coronary artery disease	2.89e-05	0.000581	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	2.89e-05	0.00058	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	2.89e-05	0.00058	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	2.89e-05	0.00058	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	2.85e-05	0.000573	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	2.85e-05	0.000573	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	2.82e-05	0.000566	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TNF—coronary artery disease	2.8e-05	0.000563	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	2.76e-05	0.000554	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPAP2B—coronary artery disease	2.7e-05	0.000543	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—UQCRFS1—coronary artery disease	2.7e-05	0.000543	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CKM—coronary artery disease	2.7e-05	0.000543	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	2.64e-05	0.000531	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	2.59e-05	0.000521	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	2.54e-05	0.000511	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH6A1—coronary artery disease	2.51e-05	0.000505	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SULT4A1—coronary artery disease	2.51e-05	0.000505	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CKMT2—coronary artery disease	2.51e-05	0.000505	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PYGM—coronary artery disease	2.51e-05	0.000505	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PDK4—coronary artery disease	2.51e-05	0.000505	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—POMC—coronary artery disease	2.51e-05	0.000503	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6—coronary artery disease	2.33e-05	0.000469	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6—coronary artery disease	2.26e-05	0.000454	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMGCS2—coronary artery disease	2.24e-05	0.00045	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PFKM—coronary artery disease	2.24e-05	0.00045	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GYG1—coronary artery disease	2.24e-05	0.00045	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GK—coronary artery disease	2.24e-05	0.00045	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LDHA—coronary artery disease	2.24e-05	0.00045	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GATM—coronary artery disease	2.24e-05	0.00045	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	2.19e-05	0.00044	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	2.19e-05	0.00044	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	2.18e-05	0.000437	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	2.16e-05	0.000434	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—AKT1—coronary artery disease	2.15e-05	0.000432	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AK1—coronary artery disease	2.14e-05	0.000429	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCH1—coronary artery disease	2.14e-05	0.000429	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	2.11e-05	0.000424	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	2.09e-05	0.00042	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT1—coronary artery disease	2.09e-05	0.000419	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—UGCG—coronary artery disease	2.05e-05	0.000412	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLCD1—coronary artery disease	2.05e-05	0.000412	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MDH2—coronary artery disease	2.05e-05	0.000412	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPAT—coronary artery disease	2.05e-05	0.000412	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PGM1—coronary artery disease	1.97e-05	0.000396	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.93e-05	0.000387	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.91e-05	0.000384	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PYGB—coronary artery disease	1.91e-05	0.000383	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CKB—coronary artery disease	1.91e-05	0.000383	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLIN1—coronary artery disease	1.79e-05	0.00036	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—DLAT—coronary artery disease	1.79e-05	0.00036	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—COX5B—coronary artery disease	1.79e-05	0.00036	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTM2—coronary artery disease	1.79e-05	0.00036	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PFKFB3—coronary artery disease	1.79e-05	0.00036	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.7e-05	0.000342	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SULT1E1—coronary artery disease	1.7e-05	0.000341	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.65e-05	0.000331	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AKR1B1—coronary artery disease	1.62e-05	0.000325	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HK2—coronary artery disease	1.62e-05	0.000325	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC27A1—coronary artery disease	1.55e-05	0.000312	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LCAT—coronary artery disease	1.52e-05	0.000306	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CPT1B—coronary artery disease	1.52e-05	0.000306	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOA4—coronary artery disease	1.49e-05	0.0003	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.47e-05	0.000295	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PDHA1—coronary artery disease	1.44e-05	0.00029	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCLM—coronary artery disease	1.44e-05	0.00029	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.4e-05	0.000281	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TXNRD1—coronary artery disease	1.4e-05	0.000281	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP11B2—coronary artery disease	1.4e-05	0.000281	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC22A3—coronary artery disease	1.38e-05	0.000277	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ARNTL—coronary artery disease	1.36e-05	0.000273	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HADH—coronary artery disease	1.36e-05	0.000273	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.34e-05	0.000268	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.3e-05	0.000262	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX2—coronary artery disease	1.29e-05	0.000258	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLA2G2A—coronary artery disease	1.29e-05	0.000258	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOA2—coronary artery disease	1.29e-05	0.000258	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCG5—coronary artery disease	1.27e-05	0.000255	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX4—coronary artery disease	1.27e-05	0.000255	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SULT1A1—coronary artery disease	1.27e-05	0.000255	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HK1—coronary artery disease	1.27e-05	0.000255	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.27e-05	0.000255	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HADHA—coronary artery disease	1.26e-05	0.000252	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTA1—coronary artery disease	1.24e-05	0.000249	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LPA—coronary artery disease	1.23e-05	0.000247	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLCB3—coronary artery disease	1.19e-05	0.000239	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOA5—coronary artery disease	1.18e-05	0.000236	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—P4HB—coronary artery disease	1.15e-05	0.000232	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.14e-05	0.00023	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLA2G1B—coronary artery disease	1.13e-05	0.000228	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.12e-05	0.000225	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.11e-05	0.000222	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—VCAN—coronary artery disease	1.07e-05	0.000215	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDOA—coronary artery disease	1.06e-05	0.000213	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—DCN—coronary artery disease	1.03e-05	0.000207	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH2—coronary artery disease	1e-05	0.000201	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	9.76e-06	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HBA1—coronary artery disease	9.75e-06	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LIPC—coronary artery disease	9.75e-06	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	9.75e-06	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOC3—coronary artery disease	9.69e-06	0.000195	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LDLR—coronary artery disease	9.63e-06	0.000193	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	9.62e-06	0.000193	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTT1—coronary artery disease	9.52e-06	0.000191	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC9A1—coronary artery disease	9.52e-06	0.000191	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCLC—coronary artery disease	9.41e-06	0.000189	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CETP—coronary artery disease	9.41e-06	0.000189	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SDC1—coronary artery disease	9.3e-06	0.000187	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PSMA6—coronary artery disease	8.79e-06	0.000177	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PSMB5—coronary artery disease	8.79e-06	0.000177	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.77e-06	0.000176	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CTGF—coronary artery disease	8.59e-06	0.000172	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMGCR—coronary artery disease	8.51e-06	0.000171	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GOT2—coronary artery disease	8.51e-06	0.000171	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLCB1—coronary artery disease	7.82e-06	0.000157	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.68e-06	0.000154	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCA1—coronary artery disease	7.58e-06	0.000152	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GOT1—coronary artery disease	7.35e-06	0.000148	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GGT1—coronary artery disease	7.35e-06	0.000148	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTP1—coronary artery disease	6.6e-06	0.000133	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	6.54e-06	0.000131	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMOX1—coronary artery disease	6.51e-06	0.000131	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CAT—coronary artery disease	6.42e-06	0.000129	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOB—coronary artery disease	6.23e-06	0.000125	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTM1—coronary artery disease	6.06e-06	0.000122	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LPL—coronary artery disease	5.95e-06	0.00012	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX1—coronary artery disease	5.81e-06	0.000117	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CD36—coronary artery disease	5.65e-06	0.000114	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPP2CA—coronary artery disease	5.58e-06	0.000112	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MTHFR—coronary artery disease	5.36e-06	0.000108	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AGT—coronary artery disease	5.09e-06	0.000102	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOE—coronary artery disease	4.99e-06	0.0001	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOA1—coronary artery disease	4.93e-06	9.9e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.72e-06	9.48e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARG—coronary artery disease	4.35e-06	8.73e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—POMC—coronary artery disease	4.29e-06	8.61e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALB—coronary artery disease	3.91e-06	7.85e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NOS3—coronary artery disease	3.74e-06	7.51e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS2—coronary artery disease	3.42e-06	6.87e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CA—coronary artery disease	2.1e-06	4.22e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AKT1—coronary artery disease	1.72e-06	3.45e-05	CbGpPWpGaD
